A microarray screen for novel candidate genes in coeliac disease pathogenesis
B Diosdado1, M C Wapenaar, L Franke
1Complex Genetics Group, Department of Biomedical Genetics, University Medical Centre, Utrecht, The Netherlands.
Background And Aims:
The causative molecular pathways underlying the pathogenesis of coeliac disease are poorly understood. To unravel novel aspects of disease pathogenesis, we used microarrays to determine changes in gene expression of duodenal biopsies.
Methods:
cDNA microarrays representing 19 200 genes were used to compare gene expression profiles of duodenal biopsies from 15 coeliac disease patients with villous atrophy (Marsh III) and seven control individuals with normal biopsies (Marsh 0). In addition, the specific effect of gluten was studied by comparing the expression profiles of Marsh III lesions of seven patients exposed to gluten with four patients on a gluten free diet.
Results:
Comparing Marsh III with Marsh 0 lesions identified 109 genes that differed significantly (p<0.001) in expression levels between patients and controls. A large number of these genes have functions in proliferation and differentiation pathways and might be important for correct development of crypt-villous units. Alterations in these pathways may lead to the characteristic hyperplasia and villous atrophy seen in coeliac disease. The analyses also revealed 120 differentially expressed genes (p<0.005) when comparing patients on a gluten free diet with those exposed to gluten. These genes further strengthen our observation of increased cell proliferation in the presence of gluten.
Conclusions:
Our study provides new candidate genes in the pathogenesis of coeliac disease. Based on our results, we hypothesise that villous atrophy in coeliac disease patients is due to failure in cell differentiation. These genes are involved in pathways not previously implicated in coeliac disease pathogenesis and they may provide new targets for therapy.
Insights
This study investigated gene expression in coeliac disease (CD) patients, revealing key genes involved in cell proliferation and differentiation. These findings suggest a failure in cell differentiation contributes to villous atrophy in CD, offering potential new therapeutic targets.
Area of Science:
- Gastroenterology and Immunology
- Molecular Biology
- Genomics
Background:
- The molecular mechanisms driving coeliac disease (CD) pathogenesis remain largely unknown.
- Understanding these pathways is crucial for developing effective treatments.
Purpose of the Study:
- To identify novel genes and pathways involved in coeliac disease pathogenesis using gene expression profiling.
- To investigate the impact of gluten exposure on gene expression in duodenal biopsies.
Main Methods:
- Utilized cDNA microarrays to analyze gene expression in duodenal biopsies from 15 CD patients (Marsh III) and 7 controls (Marsh 0).
- Compared gene expression profiles between CD patients on a gluten-free diet and those exposed to gluten.
Main Results:
- Identified 109 differentially expressed genes (p<0.001) between CD patients and controls, many linked to proliferation and differentiation pathways.
- Found 120 differentially expressed genes (p<0.005) when comparing gluten-exposed versus gluten-free conditions, supporting increased proliferation with gluten.
- These alterations in proliferation and differentiation pathways may explain the characteristic villous atrophy in coeliac disease.
Conclusions:
- Discovered novel candidate genes implicated in coeliac disease pathogenesis.
- Hypothesize that villous atrophy in CD results from impaired cell differentiation.
- Identified pathways not previously linked to CD, suggesting potential new therapeutic targets.
